Liang Xue, Tan Fei, Zhu Yunqing
School of Materials Science and Engineering, Tongji University, Shanghai, China.
Department of Orthopedics, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
Front Chem. 2021 Apr 20;9:647245. doi: 10.3389/fchem.2021.647245. eCollection 2021.
The biomedical applications of polyesters and polycarbonates are of interest due to their potential biocompatibility and biodegradability. Confined by the narrow scope of monomers and the lack of controlled polymerization routes, the biomedical-related applications of polyesters and polycarbonates remain challenging. To address this challenge, ring-opening copolymerization (ROCOP) has been exploited to prepare new alternating polyesters and polycarbonates, which would be hard to synthesize using other controlled polymerization methods. This review highlights recent advances in catalyst development, including the emerging dinuclear organometallic complexes and metal-free Lewis pair systems. The post-polymerization modification methods involved in tailoring the biomedical functions of resultant polyesters and polycarbonates are summarized. Pioneering attempts for the biomedical applications of ROCOP polyesters and polycarbonates are presented, and the future opportunities and challenges are also highlighted.
聚酯和聚碳酸酯的生物医学应用因其潜在的生物相容性和生物降解性而备受关注。由于单体范围狭窄以及缺乏可控的聚合路线,聚酯和聚碳酸酯在生物医学相关应用方面仍然具有挑战性。为应对这一挑战,已采用开环共聚(ROCOP)来制备新型交替聚酯和聚碳酸酯,而使用其他可控聚合方法则难以合成这些聚合物。本综述重点介绍了催化剂开发的最新进展,包括新兴的双核有机金属配合物和无金属路易斯对体系。总结了用于定制所得聚酯和聚碳酸酯生物医学功能的后聚合改性方法。介绍了ROCOP聚酯和聚碳酸酯在生物医学应用方面的开创性尝试,并强调了未来的机遇和挑战。